| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |